RACHEL WILLIAMS: Open Payments
NPI 1831615111 · GALESBURG, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,255 in 58 payments from 16 companies in 2025. Trend: 2023 $1,015 · 2024 $1,695 · 2025 $1,255
Food & beverage: $1,255
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 7 | $174 |
| Axsome Therapeutics, Inc. | 5 | $125 |
| Vanda Pharmaceuticals Inc. | 5 | $118 |
| Lundbeck LLC | 5 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $108 |
| ABBVIE INC. | 4 | $100 |
| Teva Pharmaceuticals USA, Inc. | 5 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $72 |
| Noven Therapeutics, LLC | 4 | $66 |
| Janssen Pharmaceuticals, Inc | 3 | $66 |
Products named: ARISTADA, REXULTI, Auvelity, CAPLYTA, FANAPT, VRAYLAR, TRINTELLIX, Xelstrym.
Industry payments across IL — which companies pay providers there.
